Latest News in the pharma Industry
Top Stories
Major breakthrough for new haemophilia A treatment
15 Dec 2017
Drug trials provide mind-blowing results.
Read more
Innovative desiccants with combined functionalities
5 Dec 2017
Sanner's AdPack and AdCap are both designed as drop-in solutions for use with moisture-sensitive products such as tablets and capsules
Read more
Major pharma company to make significant investment in the UK
28 Nov 2017
MSD's announcement to establish UK Discovery Centre in London an 'endorsement' of the government's Industry Strategy.
Read more
Key trends in formulation development for 2018
14 Nov 2017
Controlled-release technologies will continue to be focal point, whereas techniques to improve solubility are likely to gain popularity.
Read more
Recipharm to end operations in two facilities in Sweden
10 Nov 2017
Company's decision affects approximately 225 staff, specialised in tablet manufacturing, and in sachet and stick pack filling, primarily for powders and granules.
Read more
CPhI Worldwide announces the winners for its 14th Pharma awards
25 Oct 2017
19 winners chosen from 200 entries, received from nearly 30 countries worldwide.
Read more.png)
Will Novo Nordisk's semaglutide be its next blockbuster?
19 Oct 2017
Semaglutide receives positive 16-0 vote in favour of approval from FDA Advisory Committee.
Read more_Logo.jpg){kind=logo}
Boosting capabilities through collaboration
8 Oct 2017
CDMO, Micro-Sphere partners with German machine manufacturer Harro Höfliger for the latest step in its 21 million CHF (€19 million) investment into its facility in Switzerland.
Read more
Preparing for the high potency boom
29 Sep 2017
Cambrex's new HP API facility in Charles City, Iowa - one of a limited number authorized by the US DEA to import narcotic raw materials at commercial scale - to offer clients complete flexibility across scale.
Read more
Highly potent APIs - can your CMO handle them?
22 Sep 2017
The importance of ensuring a facility has the right capabilities when selecting a CMO to handle high potency ingredients.
Read more
FDA warns Pfizer company about cGMP violations associated with the manufacture of EpiPen
10 Sep 2017
Warning letter cites Meridian Medical Technologies' failure to thoroughly investigate multiple serious component and product failures of EpiPen products.
Read more
Novo Nordisk settles US federal investigation of marketing practices
7 Sep 2017
In connection with the $60 million settlement, the company has also resolved several private whistle-blower cases related to the government's investigation.
Read more